Search information leaflets for human, veterinary and plants medications, drugs, supplements, herbal, nutritional and homoeopathic products;

25-4-2017

Salin.O (2017-04-04)

Salin.O (2017-04-04)

Canada - Health Canada

21-4-2017

Pending EC decision:  Ucedane, carglumic acid, Opinion date: 21-Apr-2017

Pending EC decision: Ucedane, carglumic acid, Opinion date: 21-Apr-2017

Europe - EMA - European Medicines Agency

21-4-2017

Pending EC decision:  Febuxostat Mylan, febuxostat, Opinion date: 21-Apr-2017

Pending EC decision: Febuxostat Mylan, febuxostat, Opinion date: 21-Apr-2017

Europe - EMA - European Medicines Agency

21-4-2017

Pending EC decision:  Kevzara, sarilumab, Opinion date: 21-Apr-2017

Pending EC decision: Kevzara, sarilumab, Opinion date: 21-Apr-2017

Europe - EMA - European Medicines Agency

21-4-2017

Pending EC decision:  Celsentri, maraviroc, Opinion date: 21-Apr-2017

Pending EC decision: Celsentri, maraviroc, Opinion date: 21-Apr-2017

Europe - EMA - European Medicines Agency

21-4-2017

Pending EC decision:  Besponsa, inotuzumab ozogamicin, Opinion date: 21-Apr-2017

Pending EC decision: Besponsa, inotuzumab ozogamicin, Opinion date: 21-Apr-2017

Europe - EMA - European Medicines Agency

21-4-2017

Pending EC decision:  Avastin, bevacizumab, Opinion date: 21-Apr-2017

Pending EC decision: Avastin, bevacizumab, Opinion date: 21-Apr-2017

Europe - EMA - European Medicines Agency

21-4-2017

Pending EC decision:  Brineura, cerliponase alfa, Opinion date: 21-Apr-2017

Pending EC decision: Brineura, cerliponase alfa, Opinion date: 21-Apr-2017

Europe - EMA - European Medicines Agency

21-4-2017

Pending EC decision:  Erelzi, etanercept, Opinion date: 21-Apr-2017

Pending EC decision: Erelzi, etanercept, Opinion date: 21-Apr-2017

Europe - EMA - European Medicines Agency

21-4-2017

Pending EC decision:  Spinraza, nusinersen, Opinion date: 21-Apr-2017

Pending EC decision: Spinraza, nusinersen, Opinion date: 21-Apr-2017

Europe - EMA - European Medicines Agency

21-4-2017

Pending EC decision:  Skilarence, dimethyl fumarate, Opinion date: 21-Apr-2017

Pending EC decision: Skilarence, dimethyl fumarate, Opinion date: 21-Apr-2017

Europe - EMA - European Medicines Agency

21-4-2017

Pending EC decision:  Riximyo, rituximab, Opinion date: 21-Apr-2017

Pending EC decision: Riximyo, rituximab, Opinion date: 21-Apr-2017

Europe - EMA - European Medicines Agency

21-4-2017

Pending EC decision:  Rixathon, rituximab, Opinion date: 21-Apr-2017

Pending EC decision: Rixathon, rituximab, Opinion date: 21-Apr-2017

Europe - EMA - European Medicines Agency

21-4-2017

Pending EC decision:  Opdivo, nivolumab, Opinion date: 21-Apr-2017

Pending EC decision: Opdivo, nivolumab, Opinion date: 21-Apr-2017

Europe - EMA - European Medicines Agency

21-4-2017

Opinion/decision on a Paediatric investigation plan (PIP):    -, Baclofen, Therapeutic area: Psychiatry

Opinion/decision on a Paediatric investigation plan (PIP): -, Baclofen, Therapeutic area: Psychiatry

Europe - EFSA - European Food Safety Authority EFSA Journal

21-4-2017

Opinion/decision on a Paediatric investigation plan (PIP):    -, Alpelisib, Therapeutic area: Oncology

Opinion/decision on a Paediatric investigation plan (PIP): -, Alpelisib, Therapeutic area: Oncology

Europe - EFSA - European Food Safety Authority EFSA Journal